Fig. 2From: Survival analysis after stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a single-institution cohort studyKaplan-Meier curves showing the of overall survival (OS). Panel A: OS of the 617 early-stage lung cancer patients treated with SABR from 2010 to 2022, Panel B: OS of the 172 patients treated from 2018 to 2020 used for analysisBack to article page